The antifibrogenic effect of interferon-α is via inhibition of p38 map kinase activity

被引：0
|
作者：
Reeves, HL [1 ]
Peak, M [1 ]
Burt, AD [1 ]
Day, CP [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Inst Liver Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
GUT | 1998年 / 43卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [21] P38 MAP Kinase inhibition promotes primary tumour growth via VEGF independent mechanism
    Adrian W O'Sullivan
    Jiang H Wang
    Henry P Redmond
    World Journal of Surgical Oncology, 7
  • [22] Activity of p38 MAP kinase on the proliferation of neural progenitor cells
    Sato, Kenichiro
    Hamanoue, Makoto
    Takamatsu, Ken
    NEUROSCIENCE RESEARCH, 2006, 55 : S116 - S116
  • [23] p38 MAP kinase activity modulates αβ T cell development
    Mulroy, T
    Sen, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (10) : 3056 - 3063
  • [24] Potent inhibitors of the map kinase p38
    Henry, JR
    Rupert, KC
    Dodd, JH
    Turchi, IJ
    Wadsworth, SA
    Cavender, DE
    Schafer, PH
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
  • [25] Kinetic mechanism for p38 MAP kinase
    LoGrasso, PV
    Frantz, B
    Rolando, AM
    OKeefe, SJ
    Hermes, JD
    ONeill, EA
    BIOCHEMISTRY, 1997, 36 (34) : 10422 - 10427
  • [26] The development p38 MAP kinase inhibitors
    Hynes, John
    Wu, H.
    Dyckman, A. J.
    Lin, S.
    Wrobleski, S. T.
    Gillooly, K. M.
    McIntyre, K. W.
    Pitt, S.
    Shen, D. R.
    Shuster, D. J.
    Xia, X.
    Zhang, R.
    INFLAMMATION RESEARCH, 2007, 56 : S474 - S474
  • [27] Inhibitors of unactivated p38 MAP kinase
    Bullington, James
    Argentieri, Dennis
    Averill, Kristin
    Carter, Demetrius
    Cavender, Druie
    Fahmy, Bohumila
    Fan, Xiaodong
    Hall, Daniel
    Heintzelman, Geoffrey
    Jackson, Paul
    Leung, Wai-Ping
    Li, Xun
    Ling, Ping
    Olini, Gilbert
    Razler, Thomas
    Reuman, Michael
    Rupert, Kenneth
    Russell, Ronald
    Siekierka, John
    Wadsworth, Scott
    Wolff, Russell
    Xiang, Bangping
    Zhang, Yue-Mei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
  • [28] Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
    Marie Fisk
    Parag R. Gajendragadkar
    Kaisa M. Mäki-Petäjä
    Ian B. Wilkinson
    Joseph Cheriyan
    American Journal of Cardiovascular Drugs, 2014, 14 : 155 - 165
  • [29] INHIBITION OF p38 MAP KINASE BY UTILIZING A NOVEL ALLOSTERIC BINDING SITE
    Tong, L.
    Pargellis, C.
    Churchill, L.
    Cirillo, P.
    Gilmore, T.
    Graham, A. G.
    Grob, P. M.
    Hickey, E. R.
    Moss, N.
    Pav, S.
    Regan, J.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C231 - C231
  • [30] Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition
    Jerome, Kevin D.
    Rucker, Paul V.
    Xing, Li
    Shieh, Huey S.
    Baldus, John E.
    Selness, Shaun R.
    Letavic, Michael A.
    Braganza, John F.
    McClure, Kim F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 469 - 473
12345